1.43

0.70% 0.01

Pulmatrix Inc (PULM)

Overview News Price History Financials Discussions Forecast Stock Split

Pulmatrix Inc stock is traded at $1.43, with a volume of 13,921. It is up +0.70% in the last 24 hours and down -0.69% over the past month. Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Previous Close:

$1.42

Open:

$1.4

24h Volume:

13,921

Relative Volume:

0.80

Market Cap:

$5.22M

Revenue:

$3,000

Net Income/Loss:

$-4.53M

P/E Ratio:

-1.154

EPS:

-1.2392

Net Cash Flow:

$-4.69M

1W Performance:

+3.62%

1M Performance:

-0.69%

6M Performance:

+6.32%

1Y Performance:

-71.46%

1-Day Range:

$1.39

$1.44

1-Week Range:

$1.3403

$1.485

52-Week Range:

$1.16

$5.235

Pulmatrix Inc Stock (PULM) Company Profile

Name

Pulmatrix Inc

Sector

Healthcare (1053)

Industry

Biotechnology (595)

Phone

(888) 355-4440

Address

945 CONCORD STREET, FRAMINGHAM, MA

Employee

Twitter

@pulmatrix_inc

Next Earnings Date

null

Latest SEC Filings

PULM's Discussions on Twitter

Compare PULM vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PULM Pulmatrix Inc	1.43	5.22M	3,000	-4.53M	-4.69M	-1.2392
VRTX Vertex Pharmaceuticals Inc	514.65	130.44B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	242.08	96.65B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	807.48	83.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	869.72	54.69B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	384.50	43.50B	5.76B	514.49M	1.10B	4.4813

Pulmatrix Inc Stock (PULM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-18	Initiated	H.C. Wainwright	Buy

Pulmatrix Inc Stock (PULM) Latest News

Oct 13, 2026

Pulmatrix Files Eos PTC-2105 Preclinical Data Ahead of October 26 Merger Vote - Kalkine Media

Oct 13, 2026

Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison. - Stock Titan

Oct 13, 2026

Oct 04, 2026

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - Lelezard

Oct 04, 2026

Oct 02, 2026

No resale proceeds will go to Pulmatrix (PULM) under its amended share registration. - stocktitan.net

Oct 02, 2026

Sep 29, 2026

Pulmatrix Announces $3.0 Million Registered Direct Offering - Lelezard

Sep 29, 2026

Sep 25, 2026

Pulmatrix Files Definitive Proxy for Merger with Eos SENOLYTIX, Outlines Share Issuance and Ownership Structure - Kalkine Media

Sep 25, 2026

Pulmatrix Sets Special Meeting to Approve Merger With Eos SENOLYTIX - TipRanks

Sep 25, 2026

Sep 17, 2026

Pulmatrix (PULM) investors face 6% stake in Eos merger - Stock Titan

Sep 17, 2026

Sep 15, 2026

Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - Kalkine

Sep 15, 2026

Sep 04, 2026

Pulmatrix (NASDAQ: PULM) warns it may liquidate if Eos merger fails - Stock Titan

Sep 04, 2026

Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - kalkine.ca

Sep 04, 2026

Sep 01, 2026

Pulmatrix (PULM) Holds Steady at $1.47 as Shares Trade Between Key Support and Resistance LevelsNegative Gamma - vinanet.vn

Sep 01, 2026

Aug 19, 2026

Pulmatrix | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo

Aug 19, 2026

Aug 16, 2026

Precision Trading with Pulmatrix Inc. (PULM) Risk Zones - Stock Traders Daily

Aug 16, 2026

Aug 15, 2026

PULM Q2 2025 Earnings: Net Loss of $0.42 Per Share as Stock Moves 1.99Earnings Outlook Update - vinanet.vn

Aug 15, 2026

Pulmatrix (PULM) Gains 1.99% to $1.54 as Stock Holds Above Key SupportLong Term Entry Picks - vinanet.vn

Aug 15, 2026

Aug 14, 2026

PULM Q2 2025 Earnings: Loss of $0.42 Per Share Amid 3.97% Stock GainSubscription Growth Report - vinanet.vn

Aug 14, 2026

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Morningstar

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com South Africa

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger - TradingView

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Canada

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com UK

Aug 13, 2026

Pulmatrix posts Q2 2026 net loss $1.04M, cash $2.2M; files Form S-4 for Eos merger - TradingView

Aug 13, 2026

Pulmatrix, Inc. Q2 2026: Net loss $1.05M, EPS $(0.29) — 10-Q Summary - TradingView

Aug 13, 2026

PULM: Q2 2026 featured lower expenses, a narrowed net loss, and progress toward the Eos merger - TradingView

Aug 13, 2026

Press Release: Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Moomoo

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com India

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - PR Newswire

Aug 13, 2026

Aug 08, 2026

Pulmatrix (PULM) Holds at $1.66 as Trading Range Between $1.58 and $1.74 Defines ActionLast Point Support - vinanet.vn

Aug 08, 2026

Aug 07, 2026